Literature DB >> 27999233

Smallpox as an actual biothreat: lessons learned from its outbreak in ex-Yugoslavia in 1972.

Elizabeta Ristanovic1, Ana Gligic2, Sonja Atanasievska1, Vesna Protic-Djokic1, Dragutin Jovanovic1, Miodrag Radunovic3.   

Abstract

Variola (smallpox) virus is classified as class A of potential biological weapons, due to its microbiological, genetic, antigenic and epidemiological characteristics. The potential danger is more real because vaccination against smallpox has stopped since disease eradication in 1979. That is why we want to share our unique, rich experience and acquired knowledge in the fight against this highly contagious and deadly disease during the smallpox outbreak in ex-Yugoslavia in 1972. It was the largest postwar outbreak in Europe when there were officially registered 175 ill patients, 35 of them with lethal outcome. This outbreak was specific by the time of its occurrence, the affected territory, dimensions and some epidemiological characteristics, but also by the well-organized, synchronized and efficient reaction of the competent state services in the fight against it.

Entities:  

Mesh:

Year:  2016        PMID: 27999233     DOI: 10.4415/ANN_16_04_21

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  3 in total

Review 1.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

2.  Phylogeographical and evolutionary history of variola major virus; a question of timescales?

Authors:  Annalisa Bergna; Carla Della Ventura; Rossella Marzo; Massimo Ciccozzi; Massimo Galli; Gianguglielmo Zehender; Alessia Lai
Journal:  Infez Med       Date:  2022-03-01

3.  Health system capacity in Sydney, Australia in the event of a biological attack with smallpox.

Authors:  Chandini Raina MacIntyre; Valentina Costantino; Mohana Priya Kunasekaran
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.